1228312-14-8

Basic information

• Product Name: R-1-N-Boc-3-vinyl-pyrrolidine
• Synonyms: R-1-N-Boc-3-vinyl-pyrrolidine;(R)-tert-butyl 3-vinylpyrrolidine-1-carboxylate;tert-butyl (3R)-3-ethenylpyrrolidine-1-carboxylate
• CAS NO: 1228312-14-8
• Molecular Formula: C₁₁H₁₉NO₂
• Molecular Weight: 197.27406
• Mol File: 1228312-14-8.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: R-1-N-Boc-3-vinyl-pyrrolidine(CAS DataBase Reference)
• NIST Chemistry Reference: R-1-N-Boc-3-vinyl-pyrrolidine(1228312-14-8)
• EPA Substance Registry System: R-1-N-Boc-3-vinyl-pyrrolidine(1228312-14-8)

Safety Data

• Hazardous Substances Data: 1228312-14-8(Hazardous Substances Data)

Usage

General Description

R-1-N-Boc-3-vinyl-pyrrolidine, also known as 1-Boc-3-vinylpyrrolidine or Boc-protected 3-vinylpyrrolidine, is a chemical compound with the molecular formula C11H19NO2. It is a white to off-white solid that is commonly used as a building block in organic synthesis and medicinal chemistry. R-1-N-Boc-3-vinyl-pyrrolidine is widely utilized in the preparation of various pharmaceuticals, agrochemicals, and specialty chemicals. Its Boc (tert-butoxycarbonyl) protecting group makes it a versatile intermediate for the synthesis of a wide range of functionalized molecules. R-1-N-Boc-3-vinyl-pyrrolidine is also employed as a key starting material in the synthesis of drugs and other biologically active compounds, including antiviral and anticancer agents.

Upstream product

• 1228312-13-7 2-((R)-1-tert-butoxycarbonyl-pyrrolidin-3-yl)-malonic acid 
• 1228312-12-6 2-((R)-1-tert-butoxycarbonyl-pyrrolidin-3-yl)-malonic acid diethyl ester 
• 958026-61-4 tert-butyl (R)-3-(2-(methylsulfonyloxy)ethyl)pyrrolidine-1-carboxylate 
• 1212182-03-0 tert-butyl (3R)-3-(2-hydroxyethyl)pyrrolidine-1-carboxylate 
• 204688-60-8 (R)-3-carboxymethyl-pyrrolidin-1-carboxylic acid tert-butyl ester 
• 127423-61-4 tert-butyl (3R)-3-methylsulfonyloxypyrrolidine-1-carboxylate 
• 1779-49-3 Methyltriphenylphosphonium bromide 
• 191348-04-6 (S)-3-formylpyrrolidine-1-carboxylic acid t-butyl ester 
• 1228312-22-8 C₁₁H₂₀INO₂ 

Downstream Products

• 1228391-41-0 (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine mono-di-p-toluoyl-D-tartarate 
• 1228391-42-1 (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine mono-di-benzoyl-D-tartarate 
• 1228391-45-4 (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine mono-di-p-anisoyl-D-tartarate 
• 1380182-90-0 (S)-2-(S)-pyrrolidin-3-yl-2-(4-trifluoromethylphenoxy)ethanesulfonic acid amide trifluoroacetate 
• 1380182-97-7 (S)-3-[(S)-2-chlorosulfonyl-1-(4-trifluoromethylphenoxy)ethyl]pyrrolidine-1-carboxylic acid t-butyl ester 
• 1380182-81-9 4-oxazol-5-yl-N-[(S)-2-(S)-pyrrolidin-3-yl-2-(4-trifluoromethylphenoxy)ethyl]benzenesulfonamide trifluoroacetate 
• 1380182-96-6 (S)-3-((S)-2-amino-1-hydroxyethyl)pyrrolidine-1-carboxylic acid t-butyl ester 
• 1380182-95-5 (S)-3-((S)-2-azido-1-hydroxyethyl)pyrrolidine-1-carboxylic acid t-butyl ester 
• 1380182-93-3 (S)-3-[(S)-2-methylamino-1-(4-trifluoromethylphenoxy)ethyl]pyrrolidine-1-carboxylic acid t-butyl ester trifluoroacetate 
• 1380182-91-1 (S)-3-[(S)-2-hydroxy-1-(4-trifluoromethylphenoxy)ethyl]pyrrolidine-1-carboxylic acid t-butyl ester 
• 1380182-86-4 (S)-2-(S)-pyrrolidin-3-yl-2-(4-trifluoromethylphenoxy)ethanesulfonic acid methylamide trifluoroacetate 
• 1380182-84-2 (S)-2-(S)-pyrrolidin-3-yl-2-(4-trifluoromethylphenoxy)ethanesulfonic acid benzylamide trifluoroacetate 
• 1372149-59-1 (S)-3-[(S)-2-methanesulfonyl-1-(4-trifluoromethylphenoxy)ethyl]pyrrolidine hydrochloride salt 

Relevant articles and documents

TEAD INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

SEROTONIN REUPTAKE INHIBITORS

In one aspect, the invention relates to compounds of formula I: where X, Y, R1, R2, R3, R4, R4, and n are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.

ARYLVINYLAZACYCLOALKANE COMPOUNDS FOR CONSTIPATION

The present invention relates to methods of treating constipation and enhancing colonic motility by administration of 5-((E)-2 pyrrolidin-3-ylvinyl)pyrimidine or a pharmaceutically acceptable salt thereof.